Viemed revenues reflect organic growth, Lehan’s acquisition

LAFAYETTE, La. – Viemed Healthcare reported revenues of $76.2 million for the fourth quarter ended Dec. 31, 2025, an increase of 26% over the same quarter in 2024.

Total revenues for full-year 2025 were $270.3 million, an increase of $46 million or 21% over full-year 2024, reflecting continued strong organic growth complemented by revenue contributions from the company’s 2025 acquisition of Lehan's Medical Equipment.

Net income attributable to Viemed totaled $5.6 million for the quarter and $14.9 million for the year, an increase of 33% over full-year 2024, marking the company's ninth consecutive year of positive net income.

"Our 2025 performance reflects the continued strength of our technology-enabled home care model and the growing demand for high-quality chronic care management delivered in the home,” said Casey Hoyt, CEO. “We delivered strong double-digit organic growth by providing consistent, high-quality care that patients value and referral partners trust, driving deeper penetration across our markets. Leveraging our long-established nationwide payer network, we are expanding our maternal health offerings and extending our reach to serve more patients. With disciplined execution and platform-enhancing acquisitions, we enter 2026 with momentum and a clear focus on operational excellence, innovation, and long-term value creation."

The company is providing the following financial guidance for the year ending Dec. 31, 2026:

• Net revenue in the range of $310 million to $320 million.
• Adjusted EBITDA in the range of $65 million to $69 million.
• Net capital expenditures in the range of 10% to 11.5% of net revenue.

Related: Viemed’s diversification efforts pay off in third quarter.